The study purpose was to determine the efficacy of steroids, volume expanders and antivirals in the management of idiopathic sudden sensory neural hearing loss and to establish importance of early medical intervention. In this prospective study, thirty-four patients presenting with idiopathic sudden hearing loss of 30 db or more were enrolled in study group between 2005 and 2009. Patient variables as they related to recovery were studied and include patient age, time to onset of therapy, status of contralateral ear, presence of diabetes, severity of hearing loss, pattern of hearing loss in audiogram and presence of associated symptoms, (tinnitus, vertigo). Treatment protocol with intravenous hydrocortisone, intravenous dextran and oral anti-viral agent was followed. Pre-treatment and post-treatment pure tone average was analyzed. With combination therapy the overall improvement in pure tone threshold was seen in 27 patients (79.4%). A statistically significant association was found between the time at which medical intervention was started and hearing improvement. Early intervention in patients presenting before 3 days has given 77.8% complete type 1 recovery Idiopathic sudden sensory neural hearing loss is a medical emergency. It should not be misdiagnosed. Early detection and management with volume expanders, steroids and antivirals will improve the chances of complete recovery.
This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Hughes GB, Freedman MA, Haberkamp TJ, Guay ME (1996) Sudden sensorineural hearing loss. Otolarygol Clin North Am 29:393–405
Anderson RG, Meyerhoff WL (1983) Sudden sensory neural hearing loss. Otolaryngol Clin North Am 16:189–194
Park SN, Yeo SW, Park K-H (2006) Serum heat shock protein 70 and its correlation with clinical characteristics in patients with sudden sensory neural hearing loss. Laryngoscope 116:121–125
Capaccio P, Ottaviani F, Cuccarini V, Bottero A, Schindler A, Cesana BM, Censuales S, Pignataro L (2007) Genetic and acquired prothrombotic risk factors and sudden hearing loss. Laryngoscope 117:547–551
Choung YH, Park K, Shin YR, Cho MJ (2009) Intratympanic dexamethasone injection for refractory sudden sensory neural hearing loss. Laryngoscope 116:747–752
Westerlaken BO, de Kleine E, Van der Laan B, Albers F (2007) Treatment of sudden sensorineural hearing loss with pulse therapy: a prospective, randomized, double-blind clinical trial. Laryngoscope 117:684–690
Kim MG, Jung YG, Eun YG (2010) Effect of steroid, carbogen inhalation and lipo prostaglandin E combination therapy for sudden sensorineural hearing loss. Am J Otolaryngol 1–5
O’Malley MR, Haynes DS (2008) Sudden hearing loss. Otolaryngol Clin North Am 41(3):633–649
Nan L, Wilson WR (1983) Predictive recovery from idiopathic sudden hearing loss. Am J Otol 4:161–164
Zadeh MH, Storper IS, Spitzer JB (2003) Diagnosis and treatment of sudden onset sensorineural hearing loss: a study of 51 patients. Otolaryngol Head Neck Surg 128:92–98
Mattox DE, Lyles CA (1989) Idiopathic sudden sensorineural hearing loss. Am J Otol 10:242–247
About this article
Cite this article
Vijayendra, H., Buggaveeti, G., Parikh, B. et al. Sudden Sensorineural Hearing Loss: An Otologic Emergency. Indian J Otolaryngol Head Neck Surg 64, 1–4 (2012) doi:10.1007/s12070-010-0049-x
- Sudden sensorineural hearing loss
- Idiopathic hearing loss